The White House is preparing an executive order to expand federal research into ibogaine, a psychedelic drug used in some countries to treat PTSD, CBS News reported April 16. The Trump administration plans to keep ibogaine classified as a Schedule…
Pharmacy
GSK, a biopharmaceutical company, has withdrawn its application to the FDA for leucovorin calcium tablets, months after the White House promoted the drug as a potential treatment for autism-related symptoms, The Wall Street Journal reported April 10. The FDA approved…
At Cedar Crest Hospital in Belton, Texas, pharmacy leadership spent the past year focused on one core shift: modernizing medication distribution to improve safety in a high-risk psychiatric setting. Edith Okolo, PharmD, director of pharmacy, said 2025 marked a major…